Business

Seventh Sense Biosystems appoints new CEO, closes $10m Series A financing

Seventh Sense Biosystems, a privately held medical device company based in Cambridge, said Wednesday that Howard Weisman has been appointed president and chief executive and added that it has closed the final tranche of a $10 million Series A financing.

The financing was with existing investors Flagship Ventures and Polaris Venture Partners, the company said in a press release.

Advertisement

Founded in 2008, Seventh Sense is developing an array of products based on its proprietary painless blood collection platform.

The company said it will use the financing to complete clinical testing and to commercialize its first blood collection device for point of care diagnostics.

Get Business Headlines in your inbox:
The Globe's latest business headlines delivered every morning, Monday through Friday.
Thank you for signing up! Sign up for more newsletters here

Weisman was most recently the founder, chairman, and chief executive of EKR Therapeutics Inc., which announced its sale to Cornerstone Therapeutics in May.

According to its website, New Jersey-based EKR Therapeutics is a specialty pharmaceutical company that makes products that hospitals use for acute-care patients.

Chris Reidy can be reached at reidy@globe.com.
Loading comments...
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.